DM
HALO icon

Deerfield Management’s Halozyme HALO Stock Holding History

Deerfield Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,042
Closed -$449K – 495
2024
Q1 		$449K Buy
+11,042
New +$414K 0.01% 164
2015
Q4 		– Sell
-50,349
Closed -$676K – 117
2015
Q3 		$676K Buy
+50,349
New +$1.01M 0.03% 128

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Deerfield Management's HALO Position: Q2 2024 in Review

Deerfield Management sold out of Halozyme (HALO) in Q2 2024, closing a stake of 11,042 shares — an estimated $449K sold.

Deerfield Management first reported a position in HALO in Q3 2015 and held it in 2 quarters. The position peaked at $676K in Q3 2015. 460 funds tracked by Wall St. Rank hold HALO as of Q2 2024.

  • Deerfield Management reported no remaining Halozyme position as of Q2 2024 after selling out during the quarter.
  • Deerfield Management sold 11,042 Halozyme shares in Q2 2024, an estimated $449K.
  • Deerfield Management first reported a position in Halozyme in Q3 2015 and held it in 2 quarters.
  • Deerfield Management's Halozyme position peaked at $676K in Q3 2015.
  • 460 funds tracked by Wall St. Rank held Halozyme as of Q2 2024.

Based on Deerfield Management's 13F filing for Q2 2024, filed 14 Aug 2024.